Alvotech (ALVOW) Share-based Compensation (2022 - 2025)
Alvotech (ALVOW) reported Share-based Compensation of -$503000.0 for Q4 2025, down 97.25% on a YoY basis from -$18.3 million in Q4 2024, and down 111.27% quarter-over-quarter from $4.5 million in Q3 2025.
Alvotech (ALVOW) Share-based Compensation (2022 - 2025) Analysis & Trends
Alvotech has reported Share-based Compensation for 4 years, with the latest figure at -$503000.0 in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 97.25% year-over-year to -$503000.0; the trailing twelve-month figure through Dec 2025 stood at $7.4 million (down 3.25% YoY), and the FY2025 full-year result was $7.4 million, down 3.25% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$503000.0, down from $4.5 million in the prior quarter.
- The five-year high for Share-based Compensation was $4.5 million in Q3 2025, with the low at -$73.1 million in Q4 2022.
- Historically, Share-based Compensation has averaged -$5.5 million across 4 years, with a median of $2.5 million in 2024.
- Annual changes were most pronounced in 2023 — Share-based Compensation soared 103.88% — and 2024, when it slumped 109.0%.
- Alvotech's Share-based Compensation stood at -$73.1 million in 2022, then soared by 103.88% to $2.8 million in 2023, then slumped by 109.0% to -$255000.0 in 2024, then sank by 97.25% to -$503000.0 in 2025.
- The last three Share-based Compensation figures came in at -$503000.0 (Q4 2025), $4.5 million (Q3 2025), and $590000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | -503,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -503,000.00 |
| Dec 31, 2025 | -503,000.00 |
| Sep 30, 2025 | 4.46 Mn |
| Sep 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 590,000.00 |
| Jun 30, 2025 | 590,000.00 |
| Mar 31, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Dec 31, 2022 | -73.09 Mn |
| Dec 31, 2022 | -73.09 Mn |